InVitro International, Inc. (IVRO)
OTCMKTS
· Delayed Price · Currency is USD
0.0697
0.00 (0.00%)
Jun 5, 2025, 8:00 PM EDT
InVitro International Revenue
In the fiscal year ending September 30, 2024, InVitro International had annual revenue of $811.29K with 2.35% growth. InVitro International had revenue of $213.39K in the quarter ending September 30, 2008, with 84.11% growth.
Revenue
811.29K
Revenue Growth
-26.57%
P/S Ratio
1.95
Revenue / Employee
50.71K
Employees
16
Market Cap
1.58M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 811.29K | 18.66K | 2.35% |
Sep 30, 2023 | 792.63K | -60.88K | -7.13% |
Sep 30, 2022 | 853.51K | -149.89K | -14.94% |
Sep 30, 2021 | 1.00M | -101.41K | -9.18% |
Sep 30, 2020 | 1.10M | 52.08K | 4.95% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
InVitro International News
- 4 months ago - IVRO Announces Strong FY '25 First Quarter Sales & Net Income Advances - Newsfile Corp
- 5 months ago - IVRO Signs MOU to Merge With a European Based Non-Animal Testing Focused Organization - Newsfile Corp
- 6 months ago - InVitro International: Expectations Remain High for Animal Welfare & Growth Opportunities - Newsfile Corp
- 9 months ago - InVitro International Engages Askew Kabala and Company, Inc. to Further Advance Its Corporate Growth Plan - Newsfile Corp
- 11 months ago - InVitro International Progresses with Growth Strategies and Continues Profitability - Newsfile Corp
- 1 year ago - InVitro International Reports Positive First Half and Second Quarter FY '24 Results; Also Planning an OTC Markets Uplisting - Newsfile Corp
- 1 year ago - InVitro International Sees Real Positives in Start to FY '24 - Newsfile Corp
- 1 year ago - InVitro International Announces Fiscal Year End 2023 and Continues Positives - Newsfile Corp